There's an app for that

Houston startup plans to expand services and footprint following $2 million seed round

Ben Johnson's business idea turned into a growing company making the lives of apartment dwellers easier. Courtesy of Apartment Butler

Ben Johnson thought consolidating resident services for household chores — like doing the dishes and walking the dog — could be done more efficiently. So, he created Houston-based Apartment Butler in 2016 to do just that.

"I started thinking a lot about apartment industry," Johnson, who is the founder and CEO, says. "I just saw the industry as a whole is one that hadn't been really disrupted yet — the technology was dated."

Johnson, who worked in oil and gas banking for seven years, was commuting to Chicago on the weekends to get his MBA at the University of Chicago at the time. He was surrounded by so many people starting different types of companies. The program pulled him out of the energy industry so that he could see how something like Apartment Butler could work.

Over two years later, Johnson is fresh off a $2 million seed fund raising round that closed August 31. Houston-based Mercury Fund lead the round and Austin-based Capital Factory participated. The money raised went into growing Apartment Butler's staff. In just five months, the team has tripled from four members to 12. The company is hiring a vice president of engineering who will be based in Austin, where the technical team will also grow.

Johnson talks about more growth plans — including a footprint expansion to two new markets and new services for its users — in this week's Featured Innovator interview.

InnovationMap: How did you come up with the idea for your company?

Ben Johnson: I came up with this idea of Apartment Butler because I lived in an apartment, and I had a puppy. I would drive home at lunch to let this puppy out. There were 10 different dog walkers in my apartment community, and it made no sense to me why 10 different people would drive to this apartment community every day to walk dogs. Why can't we just come together and combine out purchasing power as a group of people and get better prices in a more efficient way?

Apartment communities for years had been aggregating things like pest control or trash service and getting a better deal. But why for these resident-elected services there was no medium for residents to broker a deal for themselves.

Separately from this idea, I was fortunate enough to catch a shift in thinking in the apartment industry. Managers and developers for years had been spending more and more money on pools and fitness centers. It had been this arms race for amenities and had been starting to think about more than just those amenities.

IM: How did you get your start?

Johnson: We had three services to start: housekeeping, pet care and dry cleaning/wash and fold.

I really had no idea what I was getting into. I was starting a three-sided platform in a city that doesn't spit out a lot of tech companies — certainly not many with a consumer-facing component. It was just like blind arrogance that led me to do this in a non-target market for startups.

One benefit to being in Houston is that i found a robust network of high networth individuals in the real estate industry that were our first capital. We were able to raise $780,000 in our first angel round in 2016. All of those individuals came from the apartment industry and then became our customers.

IM: What's been a challenge for y'all?

Johnson: Being here in Houston was a real challenge — there are entire skill sets that don't exist here. There's not technical product managers or lead engineers and you don't meet those people organically. When it came time for me to find someone to help me grow this business, it was like shooting in the dark, and I didn't yet have a network. I met someone online and, for a fee, they built our first product, and it left a lot to be desired. I think a lot of people would have stopped there.

Consumer-facing businesses are very, very hard. You look at our lead investor, Mercury Fund, which I would consider ne of the top VCs in the state, if not the country. They built a very successful series of funds doing B-to-B software. Even in Austin, which is known as a tech hub and has a vibrant startup scene doesn't have a big B-to-C presence. There's not capital for B-to-C companies in the middle of the country because the capital required to go direct to consumers is really high and the model is not nearly as predictable. Apartment Butler is not B-to-C; we have a B-to-B-to-C strategy, where we sell to the the apartments and they become our channel for customer acquisition.

IM: So, how did you manage to stand out in an environment that was so tough?

Johnson: What we're doing is unique. I didn't realize how complicated our business model was going to be.

Houston's doing a lot. It's going to be a long road. But as a city, there's a need for the largest venture capital provider in town to support companies that have gotten really good traction, whether or not it fits their mold. The city needs capital to flow into businesses

Every single VC I pitched to in wanted to require us to move to Austin as a condition to our funding. I wanted to grow this business in Houston. I thought I was going to have to move to Austin because there wasn't a VC for us here. The fact that Blair and Mercury stepped up and said, I know this is a little outside the box but this company is great for Houston. We need to keep them." And I'm glad they did.

IM: What's next for your company?

Johnson: To date, we have been delivering services that have already existed. Yes, we can provide a lower price point and have a hotel-like experience where you can just use an app and we go through your apartment office.
What we're doing now and what we're rolling out in January is our first line of microservices that haven't existed before, or only existed for the ultra-rich.
You want someone to just come in and change your bedsheets, wash your dishes, clean your bathroom, or put your groceries away. The type of experience now starts to be just what you need — a lot of people don't want to pay $70 for a whole cleaning.
The other thing would be footprint expansion. We are launching in Austin on January 7, and we'll be launching our fourth market outside of Texas in March. And then from there, we're going to rapidly accelerate how quickly we're expanding.

IM: What keeps you up at night, as it pertains to your business?

Johnson: We are creating a new industry: Resident services in apartments. I know $2 million sounds like a lot of money, but when you're hiring very talented people, it goes fast. There are 100 things I want to try — experiments I want to run to see how we can get new residents and see what works best, and I only have enough money to do 25. So, it's making sure that I try the 25 best things I can afford to do. Prioritization is what keeps me up at night.

------

Portions of this interview have been edited.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted